Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effective strategies for long-term statin use.

Gregg C Fonarow1, Karol E Watson

  • 1University of California, Los Angeles, Preventative Cardiology Program, Division of Cardiology, University of California, Los Angeles, California 90095-1679, USA. gfonarow@mednet.ucla.edu

The American Journal of Cardiology
|July 18, 2003
PubMed
Summary

Long-term statin use significantly reduces mortality in coronary artery disease patients, outperforming other treatments. Early statin initiation before hospital discharge improves adherence and clinical outcomes, saving lives.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A risk score for in-hospital death in patients admitted with ischemic or hemorrhagic stroke.

Journal of the American Heart Association·2013
Same author

American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers.

Circulation·2013
Same author

Ultrafiltration in heart failure with cardiorenal syndrome.

The New England journal of medicine·2013
Same author

Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.

The American journal of medicine·2013
Same author

Renin-Angiotensin system antagonists and mortality in patients with heart failure.

JAMA·2013
Same author

Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.

The American journal of medicine·2013

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Long-term statin therapy offers significant mortality reduction (24-42%) in coronary artery disease (CAD) patients.
  • Statin benefits in CAD patients are comparable or superior to aspirin, beta-blockers, and ACE inhibitors.
  • In diabetic patients, statins provide greater mortality reduction than intensive glycemic control.

Purpose of the Study:

  • To present evidence supporting revised national guidelines for statin initiation.
  • To highlight the benefits of initiating statins before hospital discharge.
  • To address the underuse of statin therapy in patients with atherosclerosis.

Main Methods:

  • Review of scientific evidence on long-term statin use and secondary prevention.

Related Experiment Videos

  • Analysis of studies evaluating pre-discharge statin initiation.
  • Examination of hospital-based systems to improve statin therapy adherence.

    • Main Results:

    • Pre-discharge statin initiation increases long-term treatment rates and patient compliance.
    • Early statin use leads to better low-density lipoprotein (LDL) cholesterol control (<100 mg/dL).
    • Improved clinical outcomes and significant mortality reduction are associated with optimal statin use.

    Conclusions:

    • National guidelines now recommend initiating lipid-lowering medications before hospital discharge for cardiovascular disease patients.
    • Hospital-based systems can effectively address the underuse of statin therapy.
    • Optimal statin use in high-risk individuals could prevent over 83,000 deaths annually in the US.